Status:
ACTIVE_NOT_RECRUITING
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Eligibility:
All Genders
16-29 years
Phase:
NA
Brief Summary
This research study aims to explore the feasibility and acceptability of an adapted resiliency group program, called the Relaxation Response Resiliency Program (3RP-AYA), to reduce stress and promote ...
Detailed Description
The Relaxation Response Resiliency Program, or 3RP, was developed by researchers at the MGH Benson-Henry Institute for Mind Body Medicine. The 3RP is a group program that-through a variety of mind-bod...
Eligibility Criteria
Inclusion
- Diagnosed with any cancer between ages 14 and 29
- Completed cancer treatment within the past 5 years
- At least 16 years of age at time of enrollment
Exclusion
- Unwilling or unable to participate in the study
- Unable to speak or read English
- Is medically or otherwise unable to participate (as determined by a physician or study PI)
- Unwilling or unable to participate in study sessions delivered via the Partners Telehealth videoconferencing software
- Participation in a focus group during Phase 1 (DF/HCC 17-315)
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT03768336
Start Date
April 1 2019
End Date
August 1 2025
Last Update
June 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02214